In reply: - 19/12/15
Doi : 10.1016/j.annemergmed.2015.09.029
Geoffrey Kennedy Isbister, MD, BSc
Clinical Toxicology Research Group, University of Newcastle, Newcastle, New South Wales, Australia
Department of Clinical Toxicology and Pharmacology, Calvary Mater Newcastle, Newcastle, New South Wale Australia
Leonie Calver
Clinical Toxicology Research Group, University of Newcastle, Newcastle, New South Wales, Australia
Michael A. Downes, MBBS
Clinical Toxicology Research Group, University of Newcastle, Newcastle, New South Wales, Australia
Department of Clinical Toxicology and Pharmacology and the Emergency Department, Calvary Mater Newcastle, Newcastle, New South Wale, Australia
Colin B. Page, MBChB
Clinical Toxicology Research Group, University of Newcastle, Newcastle, Australia
Emergency Department, Princess Alexandra Hospital, School of Medicine, Brisbane, Queensland, Australia
University of Queensland, Brisbane, Queensland, Australia
Le texte complet de cet article est disponible en PDF.
| Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org/). The authors have stated that no such relationships exist and provided the following detail: Dr. Isbister is supported by National Health and Medical Research Council (of Australia) Senior Research Fellowship 1061041. |
© 2015
American College of Emergency Physicians. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 67 - N° 1
P. 146-147 - janvier 2016 Retour au numéro
Article précédent
- On the Temporal Relation of Droperidol Administration and the QT Interval
- Keith A. Marill
- Naloxone Prescriptions by Emergency Physicians
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?